Clinical Focus
Business Focus
Spotlight
Subscribe
CE/CME
- CDC
- Heart Failure
- Cardiovascular Clinical Consult
- Adult Immunization
- Hepatic Disease
- Rare Disorders
- Pediatric Immunization
- Implementing The Topcon Ocular Telehealth Platform
- Weight Management
- Monkeypox
- Guidelines
- Men's Health
- Psychiatry
- Allergy
- Nutrition
- Women's Health
- Cardiology
- Substance Use
- Pediatrics
- Kidney Disease
- Genetics
- Complimentary & Alternative Medicine
- Dermatology
- Endocrinology
- Oral Medicine
- Otorhinolaryngologic Diseases
- Pain
- Gastrointestinal Disorders
- Geriatrics
- Infection
- Musculoskeletal Disorders
- Obesity
- Rheumatology
- Technology
- Cancer
- Nephrology
- Anemia
- Neurology
- Pulmonology
New Drug Improves Sleep Patterns
MINNEAPOLIS, Minn. -- Multiple measurements of a good night's sleep appear to be improved with the experimental anti-insomniac EVT 201, researchers said here.
MINNEAPOLIS, Minn., June 15 -- Multiple measurements of a good night's sleep appear to be improved with the experimental anti-insomniac EVT 201, researchers reported here.
Men taking 2.5 mg of EVT 201 averaged 430 minutes of total sleep time compared with only 412 minutes for patients taking a placebo (P=
Placebo patients averaged 412 minutes of total sleep time, while total sleep time was 430 minutes for subjects taking the 2.5 mg dose (P=
Related Content
